Step by Stepa HemeOncBuddy patient portal

DVd

Illustration: DVd

Say it: D V D

Daratumumab, bortezomib and dexamethasone

DVd is a three medicine plan for multiple myeloma that has come back, combining an antibody (daratumumab), bortezomib shots and a steroid (dexamethasone).

Also called: DVD, Dara-Vd, Dara-Bor-Dex, DBd, daratumumab bortezomib dexamethasone, Darzalex Velcade dexamethasone

What it is

Daratumumab marks myeloma cells so the immune system can destroy them. Bortezomib blocks the protein recycling system inside myeloma cells. Dexamethasone kills myeloma cells directly. After about 6 months, bortezomib and dexamethasone usually stop and daratumumab continues on its own.

Ddaratumumab
VVelcade (bortezomib)
ddexamethasone

Often used for

Three medicine phase
Cycles 1 to 8 (about 6 months) use all three medicines in 21 day cycles.
Daratumumab alone phase
From cycle 9 on, daratumumab alone is given every 4 weeks for as long as it works.
Shot vs IV daratumumab
Most people now get daratumumab as a shot under the skin, which takes only a few minutes. The IV form takes several hours.

The medicines in this plan

Daratumumab
Antibody that targets a protein (CD38) on myeloma cells. Given as a shot under the skin over a few minutes, or through a vein over several hours.
Bortezomib
Proteasome inhibitor given as a quick shot under the skin, twice a week for 2 weeks of each 3 week cycle, for 8 cycles.
Dexamethasone
Steroid taken by mouth or through a vein, on the day of and the day after each bortezomib shot.

How you get it

All three medicines are given or started in the clinic. In the first 8 cycles (21 days each), you have visits on days 1, 4, 8 and 11. Daratumumab is weekly in cycles 1 to 3, every 3 weeks in cycles 4 to 8, then every 4 weeks by itself. Your schedule may be different.

A typical cycle

Days 1, 4, 8 and 11 (cycles 1 to 8)
Bortezomib shot, with dexamethasone that day and the next.
Days 12 to 21 (cycles 1 to 8)
Rest from bortezomib. Daratumumab continues on its schedule.
Cycles 1 to 3
Daratumumab once a week.
Cycles 4 to 8
Daratumumab every 3 weeks.
Cycle 9 onward
Daratumumab alone every 4 weeks.

Common side effects and what helps

Call your care team right away if you have

Good to know

At home

Questions to ask

Multiple myeloma

Sources

Quick answers

What is DVd?
DVd is a three medicine plan for multiple myeloma that has come back, combining an antibody (daratumumab), bortezomib shots and a steroid (dexamethasone). Daratumumab, bortezomib and dexamethasone.
What does DVd stand for?
D = daratumumab; V = Velcade (bortezomib); d = dexamethasone.
How is DVd given?
All three medicines are given or started in the clinic. In the first 8 cycles (21 days each), you have visits on days 1, 4, 8 and 11. Daratumumab is weekly in cycles 1 to 3, every 3 weeks in cycles 4 to 8, then every 4 weeks by itself. Your schedule may be different.
What are the common side effects of DVd?
Tingling, numbness or burning in the hands and feet from bortezomib. Low platelets, which can cause easy bruising or bleeding. Low white blood cell counts and infections. Reactions during or after the first daratumumab dose, such as stuffy nose, cough, chills or throat tightness. Diarrhea or constipation. Tiredness. Dizziness when standing up. Trouble sleeping, mood changes and high blood sugar on dexamethasone days.
When should I call my care team during DVd?
A fever of 100.4 degrees Fahrenheit (38 degrees Celsius) or higher, or chills; Trouble breathing, wheezing or throat tightness during or after a daratumumab dose; Bleeding that will not stop, blood in your urine or stool, or many new bruises; Fainting or feeling like you will pass out; Numbness or weakness that makes it hard to walk, button clothes or hold things; Trouble breathing, chest pain, or a fast or pounding heartbeat.

Last updated: 2026-10-27. Medically reviewed by Veli Bakalov, MD, medical oncologist (October 2026). General education from Step by Step, the patient portal of HemeOncBuddy.